Investigation of the ultrasound effect and target analyte selectivity of dispersive liquid–liquid microextraction and its application to a quinocetone pharmacokinetic study

Plasma pharmacokinetics of quinocetone in ducks after oral and intravenous administration

Quinocetone (QCT), an antimicrobial growth promoter, is widely used in food-producing animals. However, information about pharmacokinetics (PK) of QCT in ducks still remains unavailable up to now. In this study, QCT and its major metabolites (1-desoxyquinocetone, di-desoxyquinocetone and 3-methyl-quinoxaline-2-carboxylic) in ducks were studied using a simple and sensitive UHPLC-MS/MS assay. Twenty ducks were divided into two groups. (n = 10/group). One group received QCT by oral administration at dose of 40 mg/kg while another group received QCT intravenously at 10 mg/kg. Plasma samples were collected at various time points from 0 to 96 hr. QCT and its major metabolites in duck plasma samples were extracted by 1 ml acetonitrile and detected by UHPLC-MS/MS, with the gradient mobile phase that consisted of 0.1% formic acid in water (A) and acetonitrile (B). A noncompartment analysis was used to calculate the PK parameters. The results showed that following oral dosing, the peak plasma concentration (C_max ) of QCT was 32.14 ng/ml and the area under the curve (AUCINF_obs) was 233.63 (h ng)/ ml. Following intravenous dosing, the C_max , AUCINF_obs and Vss_obs were 96.70 ng/ml, 152.34 (h ng)/ ml and 807.00 L/kg, respectively. These data indicated that the QCT was less absorbed in vivo following oral administration, with low bioavailability (38.43%). QCT and its major metabolites such as 1-desoxyquinocetone and 3-methyl-quinoxaline-2-carboxylic were detected at individual time points in individual ducks, while the di-desoxyquinocetone was not detected in all time points in all ducks. This study enriches basic scientific data about pharmacokinetics of QCT in ducks after oral and intravenous administration and will be beneficial for clinical application in ducks.

In-syringe low-density ionic liquid dispersive liquid–liquid microextraction for the fast determination of pyrethroid insecticides in environmental water samples by HPLC-DAD

In-syringe low-density ionic liquid dispersive liquid–liquid microextraction.

Dispersive liquid-liquid microextraction: trends in the analysis of biological samples

Dispersive liquid-liquid microextraction (DLLME) is a recent microextraction technique that was first developed by Rezaee and co-workers in 2006. It allows the simultaneous extraction and preconcentration of analytes into a micro-volume of extracting solvent based on a ternary solvent system involving an aqueous phase, a nonpolar water immiscible high-density solvent that acts as extraction phase, and a disperser solvent, which is often polar and water miscible. This article presents an overview of DLLME applications in the analysis of biological samples (e.g., plasma and urine). Aside from the classical DLLME applications using high density extraction solvents, recent advances in the use of low density solvents and ionic liquids are also discussed. Although most of the applications deal with the analysis of organic target compounds, a few applications on the bioanalysis of inorganic substances are also included.

Tissue depletion of quinocetone and its five major metabolites in pigs, broilers, and carp fed quinocetone premix

A residue depletion study was performed to investigate the tissue kinetics of quinocetone (1) and its major metabolites. Quinocetone and its major metabolites were simultaneously quantitated with a high-performance liquid chromatography-ultraviolet (HPLC-UV) method. A total of 25 pigs, 30 broilers, and 50 carp were fed 100 mg/kg quinocetone for 90, 42, and 60 days, respectively. Liver, kidney, muscle, and fat (skin) tissues were collected at five different withdrawal times for analysis. Results revealed that quinocetone, 1-desoxyquinocetone (2), carbonyl-reduced 4-desoxyquinocetone (4), 3-methylquinoxaline-2-carboxylic acid (5), and carbonyl-reduced dideoxyquinocetone (6) could be depleted quickly in tissues; by contrast, dideoxyquinocetone, 3, persisted for a long time in the liver. Therefore, the liver is possibly the target tissue of quinocetone, and 3 is the residual marker; the recommended withdrawal times (WDTs) are 0 days in pigs and carp and 3 days in broilers. These results provided clear monitoring tools and technical standards to evaluate the food safety of quinocetone.

Recent advances in unique sample preparation techniques for bioanalysis

The extraction and/or purification of drugs and medicines from biological matrices are important objectives in investigating their toxicological and pharmaceutical properties. Many widely used methods such as liquid–liquid extraction or SPE, used for extracting, purifying and enriching drugs and medicines found in biological materials, involve laborious, intensive and expensive preparatory procedures, and they require organic solvents that are toxic to both humans and the environment. Recent trends are focused on miniaturization, high-throughput and automation techniques. All the advantages and disadvantages of these techniques and devices in biological analysis are presented, and their applications in the extraction and/or purification of drugs and medicines from biological matrices are discussed in this review.